文献速递肾小球疾病遗传性与小管间质肾病

CD2AP隐性突变致人类和小鼠局灶节段性肾小球硬化

Recessive mutation in CD2AP causes focal segmental glomerulosclerosis in humans and mice.
PubMed 文献 · Kidney Int · 2018-10-26

研究通过全外显子测序在三个近亲婚配家系中发现CD2AP纯合移码突变(p.S198fs),患者儿童期起病FSGS并进展至终末期肾病;基因编辑小鼠引入相同突变后出现FSGS和肾衰竭,提供CD2AP纯合突变致人类FSGS的确凿证据。

要点

  • CD2AP纯合移码突变p.S198fs可导致儿童期起病FSGS。
  • 近亲婚配家系中三个同胞携带纯合突变并进展至终末期肾病。
  • 基因编辑小鼠引入相同突变重现FSGS和肾衰竭表型。

核心结论

  • 纯合CD2AP突变是导致人类FSGS的致病原因。

研究设计与样本

  • 研究对三个近亲婚配家系中的同胞患者进行全外显子测序,并在小鼠中通过基因编辑引入相同突变。

主要发现

  • 三个同胞携带CD2AP纯合移码突变p.S198fs,均表现为儿童期起病FSGS和终末期肾病。
  • 引入相同移码突变的小鼠发生FSGS和肾衰竭。

临床怎么用

  • 对儿童期起病FSGS患者,尤其近亲婚配家系,可考虑CD2AP基因检测以明确遗传病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although sequence variants in CD2-associated protein (CD2AP) have been identified in patients with focal segmental glomerulosclerosis (FSGS), definitive proof of causality in human disease is meager. By whole-exome sequencing, we identified a homozygous frame-shift mutation in CD2AP (p.S198fs) in three siblings born of consanguineous parents who developed childhood-onset FSGS and end stage renal disease. When the same frameshift mutation was introduced in mice by gene editing, the mice developed FSGS and kidney failure. These results provide conclusive evidence that homozygous mutation of CD2AP causes FSGS in humans.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Takano T, Bareke E, Takeda N, et al. Recessive mutation in CD2AP causes focal segmental glomerulosclerosis in humans and mice. Kidney Int. 2018. PMID: 30612599. doi:10.1016/j.kint.2018.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。